{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:13:22Z","timestamp":1791112402940,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"vor","delay-in-days":3375,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1194\/jlr.m014118","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T22:08:38Z","timestamp":1303769318000},"page":"1383-1391","source":"Crossref","is-referenced-by-count":101,"title":["PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke"],"prefix":"10.1016","volume":"52","author":[{"given":"Estelle","family":"Rousselet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Marcinkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Hatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annik","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil G.","family":"Seidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M014118_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.M014118_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.M014118_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9383","article-title":"Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia","volume":"26","author":"Allard","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1194\/jlr.M014118_bib5","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"Zaid","year":"2008","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M014118_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.M014118_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728220802600715","article-title":"PCSK9 as a therapeutic target of dyslipidemia","volume":"13","author":"Seidah","year":"2009","journal-title":"Expert Opin. Ther. Targets."},{"issue":"Suppl","key":"10.1194\/jlr.M014118_bib9","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","article-title":"PCSK9: a convertase that coordinates LDL catabolism","volume":"50","author":"Horton","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib10","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M014118_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1194\/jlr.M800027-JLR200","article-title":"Plasma PCSK9 preferentially reduces liver LDL receptors in mice","volume":"49","author":"Grefhorst","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbrc.2008.04.004","article-title":"Secreted proprotein convertase subtilisin\/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo","volume":"370","author":"Schmidt","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M014118_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/ATVBAHA.110.220988","article-title":"Circulating proprotein convertase subtilisin\/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue","volume":"31","author":"Roubtsova","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M014118_bib14","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1073\/pnas.0610879104","article-title":"Differentiation of ES cells into cerebellar neurons","volume":"104","author":"Salero","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1471-4159.2006.03928.x","article-title":"Implication of the proprotein convertase NARC-1\/PCSK9 in the development of the nervous system","volume":"98","author":"Poirier","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.M014118_bib16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biocel.2008.01.030","article-title":"The activation and physiological functions of the proprotein convertases","volume":"40","author":"Seidah","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1194\/jlr.M014118_bib17","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1073\/pnas.051630598","article-title":"An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis","volume":"98","author":"Chiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cyto.a.20346","article-title":"Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase","volume":"69","author":"Bingham","year":"2006","journal-title":"Cytometry A."},{"key":"10.1194\/jlr.M014118_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(99)01528-0","article-title":"Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation","volume":"833","author":"Belayev","year":"1999","journal-title":"Brain Res."},{"key":"10.1194\/jlr.M014118_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(02)02830-5","article-title":"Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia","volume":"946","author":"Beaulieu","year":"2002","journal-title":"Brain Res."},{"key":"10.1194\/jlr.M014118_bib21","doi-asserted-by":"crossref","first-page":"33811","DOI":"10.1074\/jbc.M503113200","article-title":"Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia","volume":"280","author":"Jiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M014118_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1998.tb10727.x","article-title":"Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins","volume":"839","author":"Seidah","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1194\/jlr.M014118_bib23","series-title":"Proteolytic and Cellular Mechanisms in Prohormone and Neuropeptide Precursor Processing","first-page":"49","article-title":"The mammalian precursor convertases: paralogs of the subtilisin\/kexin family of calcium-dependent serine proteinases","author":"Seidah","year":"1998"},{"key":"10.1194\/jlr.M014118_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0896-6273(91)90168-Y","article-title":"Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro","volume":"6","author":"Gao","year":"1991","journal-title":"Neuron."},{"key":"10.1194\/jlr.M014118_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0092-8674(90)90223-2","article-title":"The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity","volume":"61","author":"Furley","year":"1990","journal-title":"Cell."},{"key":"10.1194\/jlr.M014118_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.887941","article-title":"Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs","volume":"197","author":"Kaplan","year":"1977","journal-title":"Science."},{"key":"10.1194\/jlr.M014118_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2005.11.009","article-title":"Sustained astrocytic clusterin expression improves remodeling after brain ischemia","volume":"22","author":"Imhof","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1194\/jlr.M014118_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/00004647-200110000-00008","article-title":"Delayed, but marked, expression of apolipoprotein E is involved in tissue clearance after cerebral infarction","volume":"21","author":"Kitagawa","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1194\/jlr.M014118_bib29","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib30","doi-asserted-by":"crossref","first-page":"9820","DOI":"10.1073\/pnas.0903849106","article-title":"A proprotein convertase subtilisin\/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates","volume":"106","author":"Chan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1194\/jlr.C600025-JLR200","article-title":"Antisense inhibition of proprotein convertase subtilisin\/kexin type 9 reduces serum LDL in hyperlipidemic mice","volume":"48","author":"Graham","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib32","doi-asserted-by":"crossref","first-page":"e10682","DOI":"10.1371\/journal.pone.0010682","article-title":"A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo","volume":"5","author":"Gupta","year":"2010","journal-title":"PLoS ONE."},{"key":"10.1194\/jlr.M014118_bib33","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0805434105","article-title":"Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates","volume":"105","author":"Frank-Kamenetsky","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib34","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1194\/jlr.M006635","article-title":"PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain","volume":"51","author":"Liu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib35","doi-asserted-by":"crossref","first-page":"31791","DOI":"10.1074\/jbc.M805971200","article-title":"Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels","volume":"283","author":"Mayer","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M014118_bib36","first-page":"535","article-title":"Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review","volume":"19","author":"Lossinsky","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1194\/jlr.M014118_bib37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature."},{"key":"10.1194\/jlr.M014118_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00109-007-0172-7","article-title":"The proprotein convertases are potential targets in the treatment of dyslipidemia","volume":"85","author":"Seidah","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1194\/jlr.M014118_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neures.2007.07.004","article-title":"LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus","volume":"59","author":"Mulder","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1194\/jlr.M014118_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron."},{"key":"10.1194\/jlr.M014118_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science."},{"key":"10.1194\/jlr.M014118_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1194\/jlr.M014118_bib43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/bi00601a013","article-title":"Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins","volume":"17","author":"Innerarity","year":"1978","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M014118_bib44","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1016\/S0021-9258(18)50713-4","article-title":"Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts","volume":"254","author":"Innerarity","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M014118_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1073\/pnas.82.1.203","article-title":"Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets","volume":"82","author":"Elshourbagy","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib46","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1074\/jbc.M502143200","article-title":"The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice","volume":"280","author":"Fryer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M014118_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib48","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","article-title":"ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD","volume":"107","author":"Bryleva","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M014118_bib49","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1194\/jlr.M800542-JLR200","article-title":"Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice","volume":"50","author":"Luo","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib50","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M014118_bib51","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1\u03b1 and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M014118_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11883-010-0123-6","article-title":"The influence of PCSK9 polymorphisms on serum low-density lipoprotein cholesterol and risk of atherosclerosis","volume":"12","author":"Davignon","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.M014118_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-\u00addominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1194\/jlr.M014118_bib54","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.M014118_bib55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.ATV.0000255311.26383.2f","article-title":"A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol","volume":"27","author":"Fasano","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520370322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520370322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M014118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T14:36:54Z","timestamp":1637419014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520370322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022227520370322"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m014118","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}